NRX Pharmaceuticals Inc - Warrants (24/05/2026)
NRXPW
Get informed when a big investor buys or sells
+ FollowMarket Cap$534.62K
Close$
$0.58
3990.1% upside
Current Fair Value
3990.1% upsideUndervalued by 3990.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $534,621.00 |
|---|---|
| Enterprise Value | $-25,317,379.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.34 |
| Beta | 2.02 |
| Outstanding Shares | 37,649,382 |
Return
| Return on Equity | 13811.76% |
|---|---|
| Return on Assets | -68.74% |
| Return on Invested Capital | -7598.25% |
Valuation & Multiples
| P/E Ratio | -3.35 |
|---|---|
| PEG | 55.54 |
| Price to Sales | - |
| Price to Book Ratio | -0.01 |
| Enterprise Value to Revenue | 24.15 |
| Enterprise Value to EBIT | -3.77 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | -4.91 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 17, 2026
EPS Estimate
$0.06
Average shareholder expectationRevenue Estimate
$22.67 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.07%▼ 0.09% |
|---|---|
| Total Invested | $347▼ 85.41% |
| Investors Holding | 1▼ 2.00% |
ESG Score
No data
About NRX Pharmaceuticals Inc
2 employeesBig Rock Partners is a blank check company formed for the purpose of entering into a merger, stock exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more busi...